Table 2 Characteristics and comparison of radiological and clinical data between the ante- and retroversion groups (n = 77).
Missing data | Total | Anteversion | Retroversion | P value | |
|---|---|---|---|---|---|
n | - | 77 | 61 (79.2%) | 16 (20.8%) | N/A |
Sex (male) | 0 | 41 (53.2%) | 31 (50.8%) | 10 (62.5%) | 0.58 |
Age * | 0 | 24 (19;35) | 26 (19;35) | 22.5 (18.8;28.8) | 0.44 |
Sacral slope | 0 | 46.2 (12.7) | 51 (8.8) | 27.9 (7.5) | N/A |
Pelvic incidence | 0 | 50.8 (12.7) | 53.5 (11.7) | 40.8 (11.6) | 0.0002 |
Sagittal vertical axis (mm) | 0 | 43.2 (51.9) | 42.7 (51.6) | 45.3 (54.9) | 0.86 |
Spinosacral angle (°) | 0 | 132.1 (13.7) | 136.9 (10.1) | 113.9 (9.9) | < 0.0001 |
Functional lordosis angle | 1 | 63.8 (14.8) | 67.7 (13) | 47.7 (9.8) | < 0.0001 |
Number of vertebrae in the lumbar lordosis * | 1 | 6 (5;7) | 6 (6;7) | 5 (4;5) | < 0.0001 |
Femoral obliquity angle (°) * | 6 | 16 (10;23.5) | 14.5 (10;19.8) | 20 (14;28) | 0.06 |
Pain rating (LL or back) | 5.5 (2) | 5.5 (2.2) | 5.4 (1.1) | 0.97 | |
Pain prevalence | 0 | 48 (62.3%) | 38 (62.3%) | 10 (62.5%) | 1 |
Gait pattern | 5 | 0.51 | |||
True equinus | 18 (25%) | 16 (28.6%) | 2 (12.5%) | ||
Jump gait | 11 (15.3%) | 8 (14.3%) | 3 (18.8%) | ||
Apparent equinus | 5 (6.9%) | 5 (8.9%) | 0 (0%) | ||
Crouch gait | 21 (29.2%) | 14 (25%) | 7 (43.8%) | ||
Asymmetric gait | 10 (13.9%) | 8 (14.3%) | 2 (12.5%) | ||
Normal gait | 7 (9.7%) | 5 (8.9%) | 2 (12.5%) | ||
Orthopaedic surgery | 2 | 52 (69.3%) | 39 (66.1%) | 13 (81.2%) | 0.36 |
Surgery + neurotomy | 0 | 11 (21.2%) | 8 (20.5%) | 3 (23.1%) | 1 |
Botulinum toxin injection | 0 | 38 (49.4%) | 30 (49.2%) | 8 (50%) | 1 |
GMFCS I + II | 0 | 54 (70.1%) | 47 (87%) | 7 (13%) | 0.02 |
GMFCS III | 23 (29.9%) | 14 (60.9%) | 9 (39.1%) |
